News
10-05-2011, 03:01 AM
Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that the six-year follow-up results from the MammoSite Registry Study continue to show promising results for breast cancer patients...
More... (http://www.medicalnewstoday.com/releases/235479.php)
More... (http://www.medicalnewstoday.com/releases/235479.php)